Issues and barriers to development of clinically useful tumor markers: A development pathway proposal
- 1 June 2002
- journal article
- Published by Elsevier BV in Seminars in Oncology
- Vol. 29 (3), 213-221
- https://doi.org/10.1053/sonc.2002.32896
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapyGastroenterology, 2000
- Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancerBritish Journal of Surgery, 2000
- College of American Pathologists Conference XXXV: Solid Tumor Prognostic Factors—Which, How and So What?Archives Of Pathology & Laboratory Medicine, 2000
- Microsatellite Instability and 8p Allelic Imbalance in Stage B2 and C Colorectal CancersJNCI Journal of the National Cancer Institute, 1999
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology.Journal of Clinical Oncology, 1998
- Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology.Journal of Clinical Oncology, 1996
- Statistical aspects of prognostic factor studies in oncologyBritish Journal of Cancer, 1994
- Evaluating the Potential Usefulness of New Prognostic and Predictive Indicators on Node-Negative Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1993
- Breast Cancer Prognostic Factors: Evaluation GuidelinesJNCI Journal of the National Cancer Institute, 1991